These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 10934145)

  • 1. alpha-synuclein promotes mitochondrial deficit and oxidative stress.
    Hsu LJ; Sagara Y; Arroyo A; Rockenstein E; Sisk A; Mallory M; Wong J; Takenouchi T; Hashimoto M; Masliah E
    Am J Pathol; 2000 Aug; 157(2):401-10. PubMed ID: 10934145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
    Hashimoto M; Rockenstein E; Crews L; Masliah E
    Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult.
    Lee M; Hyun D; Halliwell B; Jenner P
    J Neurochem; 2001 Feb; 76(4):998-1009. PubMed ID: 11181819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-synuclein aggregation: a link between mitochondrial defects and Parkinson's disease?
    Lee SJ
    Antioxid Redox Signal; 2003 Jun; 5(3):337-48. PubMed ID: 12880487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of oxidative damage in protein aggregation associated with Parkinson's disease and related disorders.
    Norris EH; Giasson BI
    Antioxid Redox Signal; 2005; 7(5-6):672-84. PubMed ID: 15890012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells.
    Parihar MS; Parihar A; Fujita M; Hashimoto M; Ghafourifar P
    Int J Biochem Cell Biol; 2009 Oct; 41(10):2015-24. PubMed ID: 19460457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metallothionein attenuates 3-morpholinosydnonimine (SIN-1)-induced oxidative stress in dopaminergic neurons.
    Sharma SK; Ebadi M
    Antioxid Redox Signal; 2003 Jun; 5(3):251-64. PubMed ID: 12880480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease.
    Poon HF; Frasier M; Shreve N; Calabrese V; Wolozin B; Butterfield DA
    Neurobiol Dis; 2005 Apr; 18(3):492-8. PubMed ID: 15755676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of alpha-synuclein in a human glioma cell line and its up-regulation by interleukin-1beta.
    Tanji K; Imaizumi T; Yoshida H; Mori F; Yoshimoto M; Satoh K; Wakabayashi K
    Neuroreport; 2001 Jul; 12(9):1909-12. PubMed ID: 11435921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.
    Masliah E; Rockenstein E; Veinbergs I; Sagara Y; Mallory M; Hashimoto M; Mucke L
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12245-50. PubMed ID: 11572944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G209A mutant alpha synuclein expression specifically enhances dopamine induced oxidative damage.
    Orth M; Tabrizi SJ; Tomlinson C; Messmer K; Korlipara LV; Schapira AH; Cooper JM
    Neurochem Int; 2004 Oct; 45(5):669-76. PubMed ID: 15234109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic models of alpha-synuclein pathology: past, present, and future.
    Hashimoto M; Rockenstein E; Masliah E
    Ann N Y Acad Sci; 2003 Jun; 991():171-88. PubMed ID: 12846986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP.
    Song DD; Shults CW; Sisk A; Rockenstein E; Masliah E
    Exp Neurol; 2004 Apr; 186(2):158-72. PubMed ID: 15026254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine induces autophagic cell death and alpha-synuclein increase in human neuroblastoma SH-SY5Y cells.
    Gómez-Santos C; Ferrer I; Santidrián AF; Barrachina M; Gil J; Ambrosio S
    J Neurosci Res; 2003 Aug; 73(3):341-50. PubMed ID: 12868068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of alpha-synuclein decreased viability and enhanced sensitivity to prostaglandin E(2), hydrogen peroxide, and a nitric oxide donor in differentiated neuroblastoma cells.
    Prasad JE; Kumar B; Andreatta C; Nahreini P; Hanson AJ; Yan XD; Prasad KN
    J Neurosci Res; 2004 May; 76(3):415-22. PubMed ID: 15079871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deferoxamine attenuates iron-induced oxidative stress and prevents mitochondrial aggregation and alpha-synuclein translocation in SK-N-SH cells in culture.
    Sangchot P; Sharma S; Chetsawang B; Porter J; Govitrapong P; Ebadi M
    Dev Neurosci; 2002; 24(2-3):143-53. PubMed ID: 12401952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesis.
    Krishnan S; Chi EY; Wood SJ; Kendrick BS; Li C; Garzon-Rodriguez W; Wypych J; Randolph TW; Narhi LO; Biere AL; Citron M; Carpenter JF
    Biochemistry; 2003 Jan; 42(3):829-37. PubMed ID: 12534296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant and wild-type alpha-synuclein interact with mitochondrial cytochrome C oxidase.
    Elkon H; Don J; Melamed E; Ziv I; Shirvan A; Offen D
    J Mol Neurosci; 2002 Jun; 18(3):229-38. PubMed ID: 12059041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline, a Parkinsonism-inducing endogenous toxin, increases alpha-synuclein expression and causes nuclear damage in human dopaminergic cells.
    Shavali S; Carlson EC; Swinscoe JC; Ebadi M
    J Neurosci Res; 2004 May; 76(4):563-71. PubMed ID: 15114628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PGC-1α activity in nigral dopamine neurons determines vulnerability to α-synuclein.
    Ciron C; Zheng L; Bobela W; Knott GW; Leone TC; Kelly DP; Schneider BL
    Acta Neuropathol Commun; 2015 Apr; 3():16. PubMed ID: 25853296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.